Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts
- PMID: 1902486
- DOI: 10.1210/jcem-72-5-1169
Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts
Abstract
Fully expressed Graves' disease involves an accumulation of glycosaminoglycan (GAG) in the retroocular connective tissue which contributes to the pathogenesis of ophthalmopathy. We treated cultured retroocular and dermal fibroblasts with recombinant interferon gamma (100 U/ml) for 16-24h and measured [3H]GAG accumulation. The cytokine stimulated [3H]GAG accumulation in retroocular fibroblast cultures obtained from eight different donors by 36-124% above control values. In contrast, interferon gamma had no consistent effect on macromolecular accumulation in dermal fibroblast cultures derived from the pretibium or from areas ordinarily uninvolved in Graves' dermopathy. These results suggest that retroocular fibroblasts may be uniquely targeted for one action of interferon gamma which involves the modulation of GAG metabolism.
Similar articles
-
Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts.J Clin Endocrinol Metab. 1989 Nov;69(5):1019-23. doi: 10.1210/jcem-69-5-1019. J Clin Endocrinol Metab. 1989. PMID: 2793988
-
Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.Invest Ophthalmol Vis Sci. 1992 May;33(6):2037-42. Invest Ophthalmol Vis Sci. 1992. PMID: 1582808
-
Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy.J Clin Endocrinol Metab. 1991 Aug;73(2):307-13. doi: 10.1210/jcem-73-2-307. J Clin Endocrinol Metab. 1991. PMID: 1906894
-
Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.Thyroid. 1992 Spring;2(1):89-94. doi: 10.1089/thy.1992.2.89. Thyroid. 1992. PMID: 1525575 Review.
-
Role of connective tissue autoimmunity in Graves' ophthalmopathy.Autoimmunity. 1992;13(1):75-9. doi: 10.3109/08916939209014638. Autoimmunity. 1992. PMID: 1420809 Review.
Cited by
-
The role of cell mediated immunopathogenesis in thyroid-associated ophthalmopathy.Int J Ophthalmol. 2019 Jul 18;12(7):1209-1214. doi: 10.18240/ijo.2019.07.24. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31341815 Free PMC article. Review.
-
Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment.Int Ophthalmol. 2021 Apr;41(4):1549-1561. doi: 10.1007/s10792-021-01706-3. Epub 2021 Jan 22. Int Ophthalmol. 2021. PMID: 33481154 Review.
-
Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease.J Clin Endocrinol Metab. 2022 Aug 8;107(Suppl_1):S13-S26. doi: 10.1210/clinem/dgac328. J Clin Endocrinol Metab. 2022. PMID: 36346686 Free PMC article.
-
Immunological Aspects of Graves' Ophthalmopathy.Biomed Res Int. 2019 Nov 12;2019:7453260. doi: 10.1155/2019/7453260. eCollection 2019. Biomed Res Int. 2019. PMID: 31781640 Free PMC article. Review.
-
Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy.PeerJ. 2023 Dec 18;11:e16569. doi: 10.7717/peerj.16569. eCollection 2023. PeerJ. 2023. PMID: 38130930 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical